Translational Development Acquisition (TDAC) Stock Price

Translational Development Acquisition Price

NYSE·CLOSED
10.85
​
Market closed

Translational Development Acquisition stock price

Access this data via the Eulerpool API

Translational Development Acquisition business model & stock analysis

Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has neither engaged in any operations nor generated any revenues.

Frequently asked questions about Translational Development Acquisition

Converted at the current exchange rate, the Translational Development Acquisition share trades at 9.68 EUR (10.85 USD).

The revenue cannot currently be calculated for Translational Development Acquisition.

The profit cannot currently be calculated for Translational Development Acquisition.

The P/E ratio cannot be calculated for Translational Development Acquisition at the moment.

The P/S cannot be calculated for Translational Development Acquisition currently.

The Eulerpool Quality Score for Translational Development Acquisition is 2/10.

The ISIN of Translational Development Acquisition is KYG9008W1050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Translational Development Acquisition is TDAC. The ticker symbol is used to trade Translational Development Acquisition shares on the stock exchange.

Fair ValueTerminal
10.52 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
Dec 23, 2024
ISIN
KYG9008W1050
Cusip
G9008W105
Market capitalization
237.72 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.63 %
Last updated Oct 11, 2026, 3:49 AM

Translational Development Acquisition Peer Group